Latest news

• UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme

  In the US, Shionogi’s drug is approved under the name Fetroja for the treatment of adult patients with cUTI who have limited or no alternative treatment options. ... The US Food and Drug Administration (FDA) approval of Fetroja was based on results

• Shionogi’s novel antibiotic trial data published in The Lancet

  In the US, Shionogi’s drug is approved under the name Fetroja for the treatment of adult patients with cUTI who have limited or no alternative treatment options. ... The US Food and Drug Administration (FDA) approval of Fetroja was based on results

• Shionogi's Gram-negative antibiotic launches in the UK

  In the US, Shionogi’s drug is approved under the name Fetroja for the treatment of adult patients with cUTI who have limited or no alternative treatment options. ... The US Food and Drug Administration (FDA) approval of Fetroja was based on results

• Antibiotic biotech Melinta files for bankruptcy

  There are still players in the antibiotic and antimicrobial filed, however – Japanese pharma  Shionogi recently won FDA approval for its antimicrobial drug Fetroja, in the treatment of adults with complicated urinary

• Shionogi scores FDA approval for new cUTI antibiotic

  Pivotal new treatment for adults with complicated urinary tract infection. Japanese pharma Shionogi has won FDA approval for its antimicrobial drug Fetroja, in the treatment of adult patients with complicated urinary ... The approval of Fetroja was based